Why is Michael C. Kaufmann leaving Cardinal Health?

The filing states that Michael C. Kaufmann will depart from the company on September 1, 2022, and that his departure will entitle him to severance benefits under the Cardinal Health, Inc. Senior Executive Severance Plan. The specific reasons for his departure are not detailed in this 8-K filing beyond it being a planned transition.

What is Jason M. Hollar's background and experience?

Jason M. Hollar has been with Cardinal Health since May 2020 as Chief Financial Officer (CFO). Prior to that, he held CFO and senior finance roles at Tenneco Inc. and Sears Holding Corporation. His financial leadership experience is expected to be valuable in his new role as CEO.

How will the new CEO's compensation be structured?

Jason M. Hollar's compensation as CEO includes a base salary of $1,350,000, a target annual bonus of 150% of his salary, a target long-term incentive of $11,000,000, and an alignment grant of $3,000,000 split between PSUs and RSUs. He will also receive $350,000 for personal use of corporate aircraft.

Who is taking over as CFO, and what is their background?

Patricia M. English has been appointed as Interim CFO, effective September 1, 2022. She has served as Senior Vice President and Chief Accounting Officer at Cardinal Health since September 2020 and has held various accounting leadership roles within the company since 2011.

CAH 8-K: Leadership Changes & Regulation FD

Summary

Cardinal Health, Inc. (CAH) announced significant leadership changes via an 8-K filing on August 11, 2022, with an event date of August 6, 2022. The most impactful news for investors is the appointment of Jason M. Hollar as the new Chief Executive Officer (CEO), effective September 1, 2022. Mr. Hollar, previously the company's CFO, will succeed Michael C. Kaufmann, who is departing the company. This transition signifies a change in leadership direction, and investors will be keen to understand Mr. Hollar's strategic vision for Cardinal Health. In addition to the CEO transition, the company has appointed Patricia M. English as Interim Chief Financial Officer (CFO) and Mary C. Scherer as Senior Vice President and Chief Accounting Officer, both effective September 1, 2022. The filing also outlines the compensation packages for Mr. Hollar and Ms. English as they assume their new roles, including base salary, bonus targets, long-term incentives, and retention awards. Investors should pay attention to the details of these compensation arrangements as they reflect the company's investment in its new leadership team.

Key Highlights

1Jason M. Hollar appointed as new Chief Executive Officer (CEO), effective September 1, 2022, succeeding Michael C. Kaufmann.
2Mr. Hollar, previously CFO, has been elected as a director to the Board, effective August 11, 2022.
3Patricia M. English appointed as Interim Chief Financial Officer (CFO), effective September 1, 2022.
4Mary C. Scherer appointed as Senior Vice President and Chief Accounting Officer, effective September 1, 2022.
5Details of Mr. Hollar's new compensation package, including a base salary of $1,350,000, target annual bonus of 150%, and target long-term incentive of $11,000,000, are disclosed.
6Compensation for Ms. English includes a base salary of $300,000, additional cash compensation, a retention award, and PSU grants.
7Michael C. Kaufmann will depart the company on September 1, 2022, and is entitled to severance benefits under the company's Senior Executive Severance Plan.

CARDINAL HEALTH INC 8-K Report, Executive Changes (Aug 11, 2022)

Summary

Key Highlights

Frequently Asked Questions